As legalization for the recreational use of cannabis in Canada is fast approaching, another successful deal has been reached between an Israeli cannabis producer and an unnamed Canadian company.
It is reported that Israel’s Together has reached a deal worth over $300 million. This two-year binding deal entails purchases by the Canadian firm of dried cannabis inflorescences and medical cannabis oil from Together’s subsidiary, Globus Pharma.
This information has been adapted from Steven Scheer’s article for Reuters on June 14, 2018 titled “Israel’s Together signs $300 mln Canadian cannabis deal”. To read the complete article, please click here.